PLA2G6 and Parkinson disease: Mutations in the gene encoding phospholipase A2 group VI calcium‐independent (PLA2G6, also known as iPLA2β or iPLA2‐VIA) have been associated with two diseases: phospholipase associated neurodegeneration (PLAN, NBIA type 2) and dystonia‐parkinsonism (Table 1).